Updated Jul 16, 2026
MCGLYNN MARGARET G has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | NVAX | NOVAVAX INC | M — Option exercise | 18.9K | — | |
| 2026-04-27 | FOLD | AMICUS THERAPEUTICS, INC. | D — Derivative transaction | 94.6K | $14.50 | $1.37M |
| 2025-06-12 | NVAX | NOVAVAX INC | M — Option exercise | 10.4K | $0.00 | |
| 2025-06-05 | FOLD | AMICUS THERAPEUTICS, INC. | A — Grant or award | 20.4K | $0.00 |
MCGLYNN MARGARET G is a corporate insider — currently tracked as Director of NOVAVAX INC (NVAX). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live MCGLYNN MARGARET G profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.